AN2 Therapeutics

Menlo Park, United States

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Mar 2026

Post-IPO Equity

Biotechnology Health Care Pharmaceutical

Top Investors

RA Capital ManagementVivo CapitalBill & Melinda Gates FoundationJanus Henderson InvestorsTCG Crossover

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AN2 Therapeutics

Who are AN2 Therapeutics's investors?

AN2 Therapeutics's investors include RA Capital Management, Vivo Capital, Bill & Melinda Gates Foundation, Janus Henderson Investors, TCG Crossover.

Where is AN2 Therapeutics headquartered?

AN2 Therapeutics is headquartered in Menlo Park, United States.

What does AN2 Therapeutics do?

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

What stage is AN2 Therapeutics at?

AN2 Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 9, 2026.

MLA

"AN2 Therapeutics — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/an2-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). AN2 Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/an2-therapeutics

Wikipedia (cite web)

{{cite web |title=AN2 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/an2-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 9, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.